SMPD2 and neoplasm: Additionally, therapeutic treatments that increased SM hydrolysis via activating the surface membrane-associated nSMase allowed tumor cell apical membrane antigens exposure to the host immune effectors and prevention of an instrumental immune escape mechanism, together with accumulation of intracellular Cer [46, 69].